Inhibition of mTOR activity in diabetes mellitus reduces proteinuria but not renal accumulation of hyaluronan

References

• Steffes MW, Bilous RW, Sutherland DE, Mauer SM. Cell and matrix components of the glomerular mesangium in type I diabetes. Diabetes. 1992;41:679–84.
   PubMed Web of Science ®Google Scholar
• Mason RM, Wahab NA. Extracellular matrix metabolism in diabetic nephropathy. J Am Soc Nephrol. 2003;14:1358–73.
   PubMed Web of Science ®Google Scholar
• Lloberas N, Cruzado JM, Franquesa M, Herrero-Fresneda I, Torras J, Alperovich G, et al. Mammalian target of rapamycin pathway blockade slows progression of diabetic kidney disease in rats. J Am Soc Nephrol. 2006;17:1395–404.
   PubMed Web of Science ®Google Scholar
• Mariappan MM. Signaling mechanisms in the regulation of renal matrix metabolism in diabetes. Exp Diabetes Res. 2012;2012:749812.
   PubMed Web of Science ®Google Scholar
• Gilbert RE, Cooper ME. The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? Kidney Int. 1999;56:1627–37.
   PubMed Web of Science ®Google Scholar
• Molitch ME, DeFronzo RA, Franz MJ, Keane WF, Mogensen CE, Parving HH, et al. Nephropathy in diabetes. Diabetes Care. 2004;27:S79–83.
   PubMed Web of Science ®Google Scholar
• Najafian B, Mauer M. Progression of diabetic nephropathy in type 1 diabetic patients. Diab Res Clin Pract. 2009;83:1–8.
   PubMed Web of Science ®Google Scholar
• Melin J, Hellberg O, Funa K, Hällgren R, Larsson E, Fellström BE. Ischemia-induced renal expression of hyaluronan and CD44 in diabetic rats. Nephron Exp Nephrol. 2006;103:e86–94.
   PubMed Web of Science ®Google Scholar
• Malathy K, Kurup PA. Metabolism of glycosaminoglycans in alloxan diabetic rats. I. Changes in tissue glycosaminoglycans. Diabetes. 1972;21:1162–7.
   PubMed Web of Science ®Google Scholar
• Rügheimer L, Johnsson C, Maric C, Hansell P. Hormonal regulation of renomedullary hyaluronan. Acta Physiol (Oxf). 2008;193:191–8.
   PubMed Web of Science ®Google Scholar
• Stridh S, Palm F, Hansell P. Renal interstitial hyaluronan: functional aspects during normal and pathological conditions. Am J Physiol. 2012;302:R1235–49.
   PubMed Web of Science ®Google Scholar
• Brosius FC, Alpers CE. New targets for treatment of diabetic nephropathy: what we have learned from animal models. Curr Opin Nephrol Hypertens. 2013;22:17–25.
   PubMed Web of Science ®Google Scholar
• Kultti A, Kärnä R, Rilla K, Nurminen P, Koli E, Makkonen KM, et al. Methyl-beta-cyclodextrin suppresses hyaluronan synthesis by down-regulation of hyaluronan synthase 2 through inhibition of Akt. J Biol Chem. 2010;285:22901–10.
   PubMed Web of Science ®Google Scholar
• Laurent TC, Fraser JRE. Hyaluronan. FASEB J. 1992;6:2397–404.
   PubMed Web of Science ®Google Scholar
• Wells AF, Larsson E, Tengblad A, Fellström B, Tufveson G, Klareskog L, et al. The localization of hyaluronan in normal and rejected human kidneys. Transplantation. 1990;50:240–3.
   PubMed Web of Science ®Google Scholar
• Johnsson C, Tufveson G, Wahlberg J, Hällgren R. Experimentally-induced warm renal ischemia induces cortical accumulation of hyaluronan in the kidney. Kidney Int. 1996;50:1224–9.
   PubMed Web of Science ®Google Scholar
• Hansell P, Göransson V, Odlind C, Gerdin B, Hällgren R. Hyaluronan content in the kidney in different states of body hydration. Kidney Int. 2000;58:2061–8.
   PubMed Web of Science ®Google Scholar
• Göransson V, Johnsson C, Nylander O, Hansell P. Renomedullary and intestinal hyaluronan content during body water excess. A comparative study in rats and gerbils. J Physiol. 2002;542:315–22.
   PubMed Web of Science ®Google Scholar
• Göransson V, Johnsson C, Jacobson A, Heldin P, Hällgren R, Hansell P. Renal hyaluronan accumulation and hyaluronan synthase expression after ischaemia-reperfusion injury in the rat. Nephrol Dialys Transplant. 2004;19:823–30.
   PubMed Web of Science ®Google Scholar
• Nilsson ABM, Johnsson C, Friberg P, Hansell P. Renal cortical accumulation of hyaluronan in adult rats neonatally exposed to ACE inhibition. Acta Physiol Scand. 2001;173:343–50.
   PubMedGoogle Scholar
• Mahadevan P, Larkins RG, Fraser JR, Fosang AJ, Dunlop ME. Increased hyaluronan production in the glomeruli from diabetic rats: a link between glucose-induced prostaglandin production and reduced sulphated proteoglycan. Diabetologia. 1995;38:298–305.
   PubMed Web of Science ®Google Scholar
• Jones S, Jones S, Phillips AO. Regulation of renal proximal tubular epithelial cell hyaluronan generation: implications for diabetic nephropathy. Kidney Int. 2001;59:1739–49.
   PubMed Web of Science ®Google Scholar
• Takeda M, Babazono T, Nitta K, Iwamoto Y. High glucose stimulates hyaluronan production by renal interstitial fibroblasts through the protein kinase C and transforming growth factor-beta cascade. Metabolism. 2001;50:789–94.
   PubMed Web of Science ®Google Scholar
• Wang A, Hascall VC. Hyaluronan structures synthesized by rat mesangial cells in response to hyperglycemia induce monocyte adhesion. J Biol Chem. 2004;279:10279–85.
   PubMed Web of Science ®Google Scholar
• Rügheimer L, Carlsson C, Johnsson C, Hansell P. Renal hyaluronan content during experimental uncontrolled diabetes in rats. J Physiol Pharmacol. 2008;59:115–28.
   PubMed Web of Science ®Google Scholar
• Lewis A, Steadman R, Manley P, Craig K, de la Motte C, Hascall V, et al. Diabetic nephropathy, inflammation, hyaluronan and interstitial fibrosis. Histol Histopathol. 2008;23:731–9.
   PubMed Web of Science ®Google Scholar
• Berenson GS, Ruiz H, Dalferes ERJr, Dugan FA, Radhakrishnamurthy B. Acid mucopolysaccharide changes in diabetic kidneys. Diabetes. 1970;19:161–70.
   PubMed Web of Science ®Google Scholar
• Ikegami-Kawai M, Okuda R, Nemoto T, Inada N, Takahashi T. Enhanced activity of serum and urinary hyaluronidases in streptozotocin-induced diabetic Wistar and GK rats. Glycobiology. 2004;14:65–72.
   PubMed Web of Science ®Google Scholar
• Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell. 2006;124:471–84.
   PubMed Web of Science ®Google Scholar
• Gödel M, Hartleben B, Herbach N, Liu S, Zschiedrich S, Lu S, et al. Role of mTOR in podocyte function and diabetic nephropathy in humans and mice. J Clin Invest. 2011;121:2197–209.
   PubMed Web of Science ®Google Scholar
• Dunlop ME, Clark S, Mahadevan P, Muggli E, Larkins RG. Production of hyaluronan by glomerular mesangial cells in response to fibronectin and platelet-derived growth factor. Kidney Int. 1996;50:40–4.
   PubMed Web of Science ®Google Scholar
• Declèves AE, Caron N, Nonclercq D, Legrand A, Toubeau G, Kramp R, et al. Dynamics of hyaluronan, CD44, and inflammatory cells in the rat kidney after ischemia/reperfusion injury. Int J Mol Med. 2006;18:83–94.
   PubMed Web of Science ®Google Scholar
• Stridh S, Kerjaschki D, Chen Y, Rügheimer L, Astrand AB, Johnsson C, et al. Angiotensin converting enzyme inhibition blocks interstitial hyaluronan dissipation in the neonatal rat kidney via hyaluronan synthase 2 and hyaluronidase 1. Matrix Biol. 2011;30:62–9.
   PubMed Web of Science ®Google Scholar
• Declèves AE, Caron N, Voisin V, Legrand A, Bouby N, Kultti A, et al. Synthesis and fragmentation of hyaluronan in renal ischaemia. Nephrol Dial Transpl. 2012;27:3771–81.
   PubMed Web of Science ®Google Scholar
• Rügheimer L, Olerud J, Johnsson C, Takahashi T, Shimizu K, Hansell P. Hyaluronan synthases and hyaluronidases in the kidney during changes in hydration status. Matrix Biol. 2009;28:390–5.
   PubMed Web of Science ®Google Scholar
• Stridh S, Palm F, Hansell P. Inhibition of hyaluronan synthesis in rats reduces renal ability to excrete fluid and electrolytes during acute hydration. Ups J Med Sci. 2013;118:217–21.
   PubMed Web of Science ®Google Scholar
• Lai-Fook SJ, Brown LV, Maudgalya VS, Knapp CF, Ganesan S. Effect of increased acceleration on regional pleural pressure in dogs. J Appl Physiol. 1991;71:611–19.
   PubMed Web of Science ®Google Scholar
• Zawieja DC, Garcia C, Granger HJ. Oxygen radicals, enzymes, and fluid transport through pericardial interstitium. Am J Physiol. 1992;262:H136–43.
   PubMed Web of Science ®Google Scholar
• Wang T, Cheng HH, Heimbürger O, Chen C, Waniewski J, Bergström J, et al. Hyaluronan decreases peritoneal fluid absorption: effect of molecular weight and concentration of hyaluronan. Kidney Int. 1999;55:667–73.
   PubMed Web of Science ®Google Scholar
• Stridh S. Regulation of renal hyaluronan in water handling. Studies in vivo and in vitro. In: Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 951, Acta Universitatis Upsaliensis, Uppsala. 2013. p 1–76.
   Google Scholar
• Yang Y, Wang J, Qin L, Shou Z, Zhao J, Wang H, et al. Rapamycin prevents early steps of the development of diabetic nephropathy in rats. Am J Nephrol. 2007;27:495–502.
   PubMed Web of Science ®Google Scholar
• Mori H, Inoki K, Masutani K, Wakabayashi Y, Komai K, Nakagawa R, et al. The mTOR pathway is highly activated in diabetic nephropathy and rapamycin has a strong therapeutic potential. Biochem Biophys Res Commun. 2009;384:471–5.
   PubMed Web of Science ®Google Scholar
• Inoki K, Mori H, Wang J, Suzuki T, Hong S, Yoshida S, et al. mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice. J Clin Invest. 2011;121:2181–96.
   PubMed Web of Science ®Google Scholar
• Csóka AB, Scherer SW, Stern R. Expression analysis of six paralogous human hyaluronidase genes clustered on chromosomes 3p21 and 7q31. Genomics. 1999;60:356–61.
   PubMed Web of Science ®Google Scholar
• Ikegami-Kawai M, Suzuki A, Karita I, Takahashi T. Increased hyaluronidase activity in the kidney of streptozotocin-induced diabetic rats. J Biochem. 2003;134:875–80.
   PubMed Web of Science ®Google Scholar
• Colombaro V, Jadot I, Declèves AE, Voisin V, Giordano L, Habsch I, et al. Lack of hyaluronidases exacerbates renal post-ischemic injury, inflammation, and fibrosis. Kidney Int. 2015. [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Bardoux P, Ahloulay M, Le Maout S, Bankir L, Trinh-Trang-Tan MM. Aquaporin-2 and urea transporter-A1 are up-regulated in rats with type I diabetes mellitus. Diabetologia. 2001;44:637–45.
   PubMed Web of Science ®Google Scholar
• Zerbe RL, Vinicor F, Robertson GL. Regulation of plasma vasopressin in insulin-dependent diabetes mellitus. Am J Physiol. 1985;249:E317–25.
   PubMed Web of Science ®Google Scholar
• Brooks DP, Nutting DF, Crofton JT, Share L. Vasopressin in rats with genetic and streptozocin-induced diabetes. Diabetes. 1989;38:54–7.
   PubMed Web of Science ®Google Scholar